You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Methionine Aminopeptidase 2 Inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors, Metastatic Renal Cell Carcinoma Trial in United States (Part 1: M8891)

Terminated
Has Results
  • Advanced Solid Tumors
  • Metastatic Renal Cell Carcinoma
  • Part 1: M8891
  • New Haven, Connecticut
  • +6 more
Dec 21, 2021

Aging Trial in Orlando (Abdominal subcutaneous adipose tissue biopsy)

Active, not recruiting
  • Aging
  • Abdominal subcutaneous adipose tissue biopsy
  • Orlando, Florida
    AdventHealth Translational Research Institute
Aug 16, 2023

Triple Negative Breast Cancer Trial in Madison (Akt/ERK Inhibitor ONC201, Methionine-Restricted Diet)

Terminated
Has Results
  • Triple Negative Breast Cancer
  • Akt/ERK Inhibitor ONC201
  • Methionine-Restricted Diet
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Feb 11, 2022

Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic Trial in Iowa City (Selenomethionine (SLM),

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma Metastatic
  • Selenomethionine (SLM)
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 19, 2022

Diabetes, Type 2 Trial in Tanta (Dapagliflozin 5Mg Tab, Glimepiride 4Mg Tab)

Completed
  • Diabetes Mellitus, Type 2
  • Dapagliflozin 5Mg Tab
  • Glimepiride 4Mg Tab
  • Tanta, El-Gharbia, Egypt
    Tanta University Hospital
Aug 11, 2022

Solid Tumor Trial in United States (IDE397, Docetaxel, Paclitaxel)

Recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +10 more
Jul 20, 2022

Healthy Trial in Toronto (Sulphur amino acids)

Recruiting
  • Healthy
  • Sulphur amino acids
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Jan 14, 2022

HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer Trial (Evexomostat)

Not yet recruiting
  • HR+/HER2-negative Breast Cancer
  • Metastatic Breast Cancer
  • (no location specified)
Jul 7, 2022

Fetal Pancreatic Size and Maternal Serum Biomarkers in GDM

Completed
  • Gestational Diabetes
    • İstanbul, Turkey
      Haseki Training and Research Hospital
    May 26, 2022

    Stable Neonates, Receiving Total Parenteral Nutrition (TPN) Trial in Toronto (Total parenteral nutrition (TPN). This is total

    Recruiting
    • Stable Neonates
    • Receiving Total Parenteral Nutrition (TPN)
    • Total parenteral nutrition (TPN). This is total nutrition provided by central vein.
    • Toronto, Ontario, Canada
      Glenda Courtney-Martin
    Oct 24, 2022

    Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston (Azacitidine, Cytarabine, Tosedostat)

    Terminated
    • Acute Myeloid Leukemia
    • High Risk Myelodysplastic Syndrome
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 9, 2020

    Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Birmingham, Alabama
    • +2 more
    Jan 3, 2023

    Breast Cancer, Triple Negative Breast Cancer Trial in Madison (hominex-2)

    Terminated
    • Breast Cancer
    • Triple Negative Breast Cancer
    • hominex-2
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Aug 16, 2021

    Remaxol® Used in Treatment of Gallstone Disease Complicated With

    Recruiting
    • Gallstone Disease
    • Obstructive Jaundice
    • Barnaul, Russian Federation
    • +8 more
    Jun 28, 2023

    Insulin Resistance Syndrome Trial in France (Dosage of IRAP during OGTT)

    Terminated
    • Insulin Resistance Syndrome
    • Dosage of IRAP during OGTT
    • Clermont-Ferrand, France
    • +3 more
    Aug 8, 2022

    Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

    Not yet recruiting
    • Chronic Kidney Disease
    • Part A - Lorundrostat QD + Dapaglifozin QD
    • +2 more
    • (no location specified)
    Nov 27, 2023

    Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

    Recruiting
    • Her-2 Negative Breast Cancer
    • HRR Gene Mutation
    • Guangzhou, Guangdong, China
      First Affiliated Hospital, Sun Yat-Sen University
    Mar 7, 2023

    CNS Tumor, Head and Neck Tumors Trial in Memphis (L-(11C) methionine)

    Available
    • Central Nervous System Tumor
    • Head and Neck Neoplasms
    • L-(11C) methionine
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Aug 19, 2022

    NSCLC Trial in Singapore (Ipilimumab, Nivolumab)

    Terminated
    • Non-Small Cell Lung Cancer
    • Singapore, Singapore
    • +2 more
    Jun 10, 2022

    Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

    Not yet recruiting
    • Adenoid Cystic Carcinoma
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 14, 2023

    Metastatic Breast Cancer Trial in Herlev, Vejle (PARP inhibitor 2X-121)

    Active, not recruiting
    • Metastatic Breast Cancer
    • PARP inhibitor 2X-121
    • Herlev, Denmark
    • +1 more
    Feb 1, 2023

    Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

    Not yet recruiting
    • Diabetes Mellitus
    • +2 more
    • Seoul, Korea, Republic of
      Yonsei University College of Medicine
    Aug 1, 2023

    Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

    Not yet recruiting
    • Recurrent Head and Neck Cancer
    • +5 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 30, 2023

    Determine Pro-Inflammatory Cytokine Kinetics During Immune

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Melanoma
      • Indianapolis, Indiana
        Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
      Jan 30, 2023

      Solid Tumors, NSCLC, CRC Trial in United States (Telaglenestat (CB-839), Palbociclib Oral Capsule or Tablet [Ibrance])

      Completed
      • Solid Tumors
      • +3 more
      • Telaglenestat (CB-839)
      • Palbociclib Oral Capsule or Tablet [Ibrance]
      • Santa Monica, California
      • +9 more
      Sep 14, 2022